20 August 2026

Clinical research Rheumatoid Arthritis

Bispecific T-cell engager may ‘reset’ drug resistance in refractory RA

4 September 2025

Pharmaceuticals

Ianalumab hits phase III milestone in Sjögren’s

10 July 2025

FDA

FDA approves first treatment for life-threatening MAS in Still’s disease patients

17 April 2025

Respiratory

Tezepelumab reduces polyps, congestion in chronic rhinosinusitis

6 March 2025

PBS Psoriatic Athritis

PBS rizz for new psoriatic arthritis drug

20 February 2025

Lupus Pharmaceuticals

New phase 3 success in lupus nephritis